International Psoriasis Council

Advancing Knowledge. Improving Care.

Maria Gkini headshot

Maria-Angeliki

Gkini

,

MD, MSc, PhD, FRCP

Consultant Dermatologist and Honorary Senior Lecturer
Barts Health NHS Trust and Queen Mary University
London
,
United Kingdom
2023 Fellow
IPC Jr. Councilor
Dr. Maria-Angeliki Gkini qualified from the Medical School of Aristotle University in Thessaloniki, Greece. She is an MSc holder in International Medicine-Health Crisis Management, and she completed her PhD, focusing on managing hair diseases. She completed her dermatology training at Barts Health NHS Trust in London, focusing on managing inflammatory skin diseases. She further pursued her clinical and research interests in Athens, Greece, and New York City, United States. She was a 2023 IPC Fellow and was mentored and hosted by Prof Alice Gottlieb at Mount Sinai. She is a Fellow of the Royal College of Physicians.

She is a Consultant Dermatologist at Barts Health NHS Trust, London, United Kingdom, and an Honorary Senior Lecturer at Queen Mary University. She runs the specialist medical dermatology (psoriasis, atopic dermatitis, and hidradenitis suppurativa) and psychodermatology clinics. Her special interests include inflammatory skin diseases, advanced therapies (biologics and small molecules), hair diseases, and psychodermatology. Besides her clinical work, Dr Gkini is interested in clinical research and has been a principal and sub-investigator in more than 50 multicenter studies. She has significant teaching experience, including teaching at the Postgraduate Diploma in Clinical Dermatology at Queen Mary University in London.

Dr. Gkini is actively involved in several organisations and societies and their committees, such as the European Academy of Dermatology and Venereology (EADV), the European Society of Dermatopathology (ESDAP), the IPC, and Alopecia United Kingdom. She has participated in numerous national and international congresses as a speaker/invited speaker, and she has published her research in peer-reviewed international journals. Dr. Gkini has also been awarded multiple prizes and grants by prestigious institutions and organisations, such as the EADV, the British Association of Dermatologists (BAD), and the Royal College of Physicians.
Last Updated:
02/11/2025

IPC Committees / Groups

Diverse Skin Types Working Group, Membership Committee

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026